Authors: Piek, JMJ van Diest, PJ Zweemer, RP Jansen, JW Poort-Keesom, RJJ Menko, FH Gille, JJP Jongsma, APM Pals, G Kenemans, P Verheijen, RHM

Citation: Jmj. Piek et al., Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer, J PATHOLOGY, 195(4), 2001, pp. 451-456

Authors: Westerhoff, HV Riethorst, A Jongsma, APM

Citation: Hv. Westerhoff et al., Relating multidrug resistance phenotypes to the kinetic properties of their drug-efflux pumps, EUR J BIOCH, 267(17), 2000, pp. 5355-5368

Authors: Jongsma, APM Riethorst, A Lankelma, J Dekker, H Westerhoff, HV

Citation: Apm. Jongsma et al., Evaluating limited specificity of drug pumps - Reduced relative resistancein human MDR phenotypes, EUR J BIOCH, 267(17), 2000, pp. 5369-5377

Authors: Bergman, AM Pinedo, HM Jongsma, APM Brouwer, M van Haperen, VWTR Veerman, G Leyva, A Eriksson, S Peters, GJ

Citation: Am. Bergman et al., Decreased resistance to gemcitabine (2 ',2 '-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: Role of altered activity and substrate specificity of deoxycytidine kinase, BIOCH PHARM, 57(4), 1999, pp. 397-406